Fulgent Genetics (FRA:7F0) Operating Cash Flow per Share : €1.31 (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Fulgent Genetics Operating Cash Flow per Share?

Fulgent Genetics's operating cash flow per share for the three months ended in Mar. 2024 was €0.23. Fulgent Genetics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €1.31.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Fulgent Genetics was -23.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -46.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Fulgent Genetics's Operating Cash Flow per Share or its related term are showing as below:

FRA:7F0' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -46.3 Med: 20.6 Max: 327.2
Current: -46.3

During the past 10 years, Fulgent Genetics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 327.20% per year. The lowest was -46.30% per year. And the median was 20.60% per year.

FRA:7F0's 3-Year OCF Growth Rate is ranked worse than
90.96% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.4 vs FRA:7F0: -46.30

Fulgent Genetics Operating Cash Flow per Share Historical Data

The historical data trend for Fulgent Genetics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Operating Cash Flow per Share Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.27

4.81

15.39

7.73

0.83

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.25	0.30	0.32	0.46	0.23

Competitive Comparison of Fulgent Genetics's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Price-to-Operating-Cash-Flow falls into.

Fulgent Genetics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Fulgent Genetics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	24.762	/	29.784
	=	0.83

Fulgent Genetics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	6.685	/	29.769
	=	0.22

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.31

Fulgent Genetics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (FRA:7F0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (FRA:7F0) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics (FRA:7F0) Headlines

No Headlines